Cerebral venous occlusion represents an often underdiagnosed cause for acute or slowly progressive neurological deterioration. The underlying pathophysiological basis is not well understood, but is different from those of arterial occlusion reflecting therefore different anatomical and physiological features of the cerebral venous system. Extensive collateral circulation within the cerebral venous system allows for a significant degree of compensation in the early stages of venous occlusion. Elevated cerebral venous pressure due to cerebral venous occlusion can result in a spectrum of phenomena including a dilated venous and capillary bed, development of interstitial edema, increased cerebrospinal fluid production, decreased cerebrospinal fluid absorption and rupture of venous structures (hematoma). All of these pathophysiological changes may explain the clinical observation that cerebral venous occlusion, if promptly diagnosed and adequately managed, contains reversible alterations and need not always lead to venous infarction. The present review outlines this different pathophysiological behavior of venous compared to arterial occlusion in the cerebral vasculature; special reference is given to the effect of these changes on the therapeutic impact.

1.
Arai H, Sato K, Okuda O, et al: Transcranial transphenoidal approach for tuberculum sellae meningiomas. Acta Neurochir (Wien) 2000;142:751–757.
2.
Schmidek HH, Auer LM, Kapp JP: The cerebral venous system. Neurosurgery 1985;17:633–678.
3.
Rother J, Waggie K, van Bruggen N, et al: Experimental cerebral venous thrombosis: Evaluation using magnetic resonance imaging. J Cereb Blood Flow Metab 1996;16:1353–1361.
4.
Schoser BGH, Riemenschneider N, Hansen HC: The impact of raised intracranial pressure on cerebral venous hemodynamics: A prospective venous transcranial Doppler ultrasonography study. J Neurosurg 1999;91:744–749.
5.
Krayenbühl H: Cerebral venous and sinus thrombosis; in Ojemann RG, Shilito J Jr (eds): Clinical Neurosurgery. Baltimore, Williams & Wilkins, vol 14, pp 1–24.
6.
Einhäupl KM, Villringer A, Meister W, et al: Heparin treatment in sinus venous thrombosis. Lancet 1991;338:597–600.
7.
Lövblad KO, Bassetti C, Schneider J, et al: Diffusion-weighted MR in cerebral venous thrombosis. Cerebrovasc Dis 2001;11:169–176.
8.
Schaller B, Graf R, Wienhard K, et al: A new animal model of cerebral venous infartion: Ligation of the posterior part of the superior sagittal sinus in the cat. Swiss Med Wkly 2003;133:412–418.
9.
Schaller B, Graf R, Sanada Y, et al: Hemodynamic changes after occlusion of the posterior superior sagittal sinus: An experimental PET-study in cats. AJNR 2003;24:1876–1880.
10.
Schaller B, Graf R, Jacobs AH: Ischemic tolerance: A window to endogenous neuroprotection? Lancet 2003;362:1007–1008.
11.
Schaller B, Graf R: Cerebral ischemia and reperfusion: The pathophysiological concept as basis of clinical therapy? J Cereb Blood Flow Metab 2004;24:351–371.
12.
Sakata K, Kamamoto I, Sekino T: Preoperative angiographic examination of the sylvian drainage system: The rationale of intentional division of the bridgine vein running of the temporal tip; in Hakuba A (ed): Surgery of the Intracranial Venous System. Berlin, Springer, 1996, pp 163–168.
13.
Friedman DP: Abnormalities of the deep medullary white matter veins: MR imaging findings. AJR 1997;168:1103–1108.
14.
Ungersbock K, Heimann A, Kempski O: Cerebral blood flow alterations in a rat model of cerebral sinus thrombosis. Stroke 1993;24:563–569.
15.
Nakase H, Kakizaki T, Miyamoto K, et al: Use of local cerebral blood flow monitoring to predict brain damage after disturbances to the venous circulation: Cortical vein occlusion model by photochemical dye. Neurosurgery 1995;37:280–286.
16.
Miyamoto K, Heimann A, Kempski O: Microcirculatory alterations in a Mongolian gerbil sinus-vein thrombosis model. J Clin Neurosci 2001;8(suppl 1):97–105.
17.
Ueda K, Nakase H, Miyamoto K, et al: Impact of anatomical difference of the cerebral venous system on microcirculation in a gerbil superior sagittal sinus occlusion model. Acta Neurochir (Wien) 2000;142:75–82.
18.
Frerichs KU, Deckert M, Kempski O, et al: Cerebral sinus and venous thrombosis in rats induces long-term deficits in brain function and morphology – Evidence for a cytotoxic genesis. J Cereb Blood Flow Metab 1994;14:289–300.
19.
Robertson JB Jr, Brackmann DE, Fayad JN: Complications of venous insufficiency after neurologic skull base surgery. Am J Otol 2000;21:701–705.
20.
Nakase H, Kempski OS, Heimann A, et al: Microcirculation after cerebral venous occlusion as assessed by laser Doppler scanning. J Neurosurg 1997;87:307–314.
21.
Tsai FY, Wang AM, Matovich VB, et al: MR staging of acute dural sinus thrombosis: Correlation with venous pressure measurements and implications for treatment and prognosis. AJNR 1995;16:1021–1029.
22.
Gotoh M, Ohmoto T, Kuyama H: Experimental study of venous circulatory disturbance by dural sinus occlusion. Acta Neurochir (Wien) 1993;124:120–126.
23.
Fujita K, Kojima N, Tamaki N, et al: Brain edema in intracranial venous hypertension; in Inaba Y, Klatzo I, Spatz M (eds): Brain Edema. Tokyo, Springer, 1985, pp 228–234.
24.
Yuh WTC, Simonson TM, Wang AM, et al: Venous sinus occlusive disease: MR findings. Am J Neuroradiol 1994;15:309–316.
25.
Yasargil MG, Damur M: Thrombosis of the cerebral veins and sinuses; in Newton TH, Potts DG (eds): Radiology of the Skull and Brain: Angiography. St Louis, Mosby, 1974.
26.
Bering EAJ, Salibi B: Production of hydrocephalus by increased cephalic-venous pressure. AMA Arch Neurol Psychiatry 1959;81:47/693–52/698.
27.
Garcia JH: Thrombosis of cranial veins and sinuses: Brain parenchymal effects; in Einhäupl K, Kempski O, Baethmann A (eds): Cerebral Sinus Thrombosis: Experimental and Clinical Aspects. New York, Plenum Press, 1990, 27–38.
28.
Fries G, Wallenfang T, Hennen J, et al: Occlusion of the pig superior sagittal sinus, bridging and crotical veins: Multistep evolution of sinus-vein thrombosis. J Neurosurg 1992;77:127–133.
29.
Fujita K, Kojima N, Tamaki N, et al: Brain edema in intracranial venous hypertension; in Inaba Y, Klatzo I, Spatz M (eds): Brain Edema. Tokyo, Springer, 1985, pp 228–234.
30.
Sato S, Miyahara Y, Dohmoto Y, et al: Cerebral microcirculation in experimental sagittal sinus occlusion in dogs; in Auer LM, Lowe F (eds): The Cerebral Veins. New York, Springer, 1984, pp 111–117.
31.
Bousser MG, Barnett HJM: Cerebral venous thrombosis; in Barnett HLM, Mohr JP, Stein BM, Yatsu FM (eds): Stroke: Pathophysiology, Diagnosis and Management, ed 2. New York, Churchill Livingstone, 1992.
32.
Schaller B, Graf R: Cerebral ischemic preconditioning: An experimental phenomenon or clinical important entity of stroke prevention? J Neurol 2002;11:1503–1511.
33.
Yoshimoto Y, Endo M, Mori T, et al: Correlation between venous stump pressure and brain damage after cortical vein occlusion: An experimental study. J Neurosurg 1997;86:694–698.
34.
Kurokawa Y, Hashi K, Okuyama T, et al: Regional ischemia in cerebral venous hypertension due to embolic occlusion of the superior sagittal sinus in the rat. Surg Neurol 1990;34:390–395.
35.
Gotoh M, Ohmoto T, Kuyama H: Experimental study of venous circulatory disturbance by fural sinus occlusion. Acta Neurochir (Wien) 1993;124:120–126.
36.
Bousser MG, Chiras J, Bories J, et al: Cerebral venous thrombosis – A review of 38 areas. Stroke 1985;16:199–213.
37.
Kristensein B, Malm J, Markgren P, et al: CSF hydrodynamics in superior sagittal sinus thrombosis. J Neurol Neurosurg Psychiatry 1992;4:287–293.
38.
Wagner E, Traystman R: Effects of cerebral venous and cerebrospinal fluid pressure on cerebral blood flow; in Auer L, Löw F (eds): The Cerebral Veins. Vienna, Springer, 1984, pp 223–230.
39.
Marmarou A, Shulman K, LaMorgense J: Compartmental analysis of compliance and outflow resistance of the cerebrospinal fluid system. J Neurosurg 1975;43:523–534.
40.
Sano H, Kawase T, Toya S: The changes in the cerebral microcirculation during increased intracranial pressure; in Auer LM, Löw F (eds): The Cerebral Veins. Vienna, Springer, 1984, pp 231–238.
41.
Kotani J, Adachi R, Fujita N, et al: Effect of cerebral venous congestion on the pressure-volume index in the evaluation of intracranial pressure dynamics. J Neurosurg Anesthesiol 1993;5:121–126.
42.
Chai JP, Skaryak LA, Ungerleider RM, et al: Jugular ligation does not increase pressure but does increase bihemispheric cerebral blood flow and metabolism. Crit Care Med 1995;23:1864–1871.
43.
Collins RC, Borowsky IW: Metabolic anatomy of brain: A comparison of regional capillary density, glucose metabolism and enzyme activities. J Comp Neurol 1989;288:401–413.
44.
Kikano GE, LaManna JC, Harik SI: Brain perfusion in acute and chronic hyperglycemia in rats. Stroke 1989;20:1027–1031.
45.
Long DM: Microvascular changes in cold injury edema; in Go KG, Baethman A (eds): Recent Progress in the Study and Therapy of Brain Edema. New York, Plenum Press, 1984.
46.
Iannotti F, Hoff JT, Schielke GP: Brain tissue pressure in focal cerebral ischemia. J Neurosurg 1985;62:83–89.
47.
Turcani P, Gotoh F, Ishihara N, et al: Are blood platelets involved in the pathogenesis of ischemic brain edema in gerbils? Stroke 1988;19:486–489.
48.
Grogaard B, Schjurer L, Gerdin B, et al: Delayed hypoperfusion after incomplete forebrain ischemia in the rat: The role of polymorphonuclear leukocytes. J Cereb Blood Flow Metab 1989;9:500–505.
49.
Chiang J, Kowada M, Ames A, et al: Cerebral ischemia III: Vascular changes. Am J Pathol 1986;52:45–76.
50.
Palkarvi L, Rehncorna S, Sonderfeldt B, et al: Brain lactic acidosis and ischemic cell damage: Quantitative ultrastructural changes in capillaries of rat cerebral cortex. Acta Neuropathol (Berl) 1983;60:232–240.
51.
Nakase H, Nagata K, Otsuka H, et al: Local cerebral blood flow autoregulation following ‘asymptomatic’ cerebral venous occlusion in the rat. J Neurosurg 1998;89:118–124.
52.
De Bruijn SFTM, Stam J, for the Cerebral Venous Sinus Thrombosis Group: Randomized placebo-controlled trial of anticoagulant treatment with low molecular weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484–488.
53.
Govier AV, Reves JG, McKay RD, et al: Factors and the influence on regional cerebral blood flow during nonpulsatile cardiopulmonary bypass. Ann Thorac Surg 1984;38:592–600.
54.
Gloor P, Ball G, Schaul N: Brain lesions that produce delta waves in the EEG. Neurology 1977;27:326–333.
55.
Hossmann KA: Periinfarct depolarization. Cerebrovasc Brain Metab Rev 1996;8:195–208.
56.
Back T, Ginsberg M, Dietrich WD, et al: Induction of spreading depression in the ischemic hemisphere following experimental middle cerebral artery occlusion: Effect on infarct morphology. J Cereb Blood Flow Metab 1996;16:202–213.
57.
Astrup J, Siesjö BK, Symon L: Threshold in cerebral ischemia: The ischemic penumbra. Stroke 1981;12:723–725.
58.
Hachinski VC, Wilson JX, Smith KE, et al: Effect of age on autonomic and cardiac responses in the rat stroke model. Arch Neurol 1992;49:690–696.
59.
Jacobson I, Harper AM, McDowall DG: Relationship between venous pressure and cortical blood flow. Nature 1963;200:173–175.
60.
Ekström-Jodal B: Effect of increased venous pressure on cerebral blood flow in dogs. Acta Physiol Scand (Suppl) 1970;350:51–61.
61.
Stam J, De Bruuijn SFTM, deVeber G: Anticoagulation for cerebral sinus thrombosis. Stroke 2003;34:1054–1055.
62.
Kim KS, Weinberg PE: Venous cerebral infarction. Surg Neurol 1981;15:118–124.
63.
Emerson TE Jr, Parker JL: Effects of local increases of venous pressure on canine cerebral hemodynamics; in Langfitt TW, McHenry LC Jr, Reivich M, Wollman H (eds): Cerebral Circulation and Metabolism. New York, Springer, 1975, pp 10–13.
64.
Raisis JE, Kindt GW, McGillicuddy JE, et al: The effect of primary elevation of cerebral venous pressure on cerebral hemodynamics and intracranial pressure. J Surg Res 1979;26:101–107.
65.
Kurokowa Y, Hashi K, Okuyama T, et al: Regional ischemia in cerebral venous hypertension due to embolic occlusion of the superior sagittal sinus in the rat. Surg Neurol 1990;34:390–395.
66.
Yoshimoto Y, Endo M, Mori T, et al: Correlation between venous stump pressure and brain damage after cortical vein occlusion: an experimental study. J Neurosurg 1997;86:694–698.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.